FIELD: medicine.
SUBSTANCE: invention can be applicable for treating patients suffering haemorrhagic shock. Namely, the invention refers to a hyperoxygenated agent for venous oxygen saturation, which represents an aqueous solution containing sodium chloride 0.85%, sodium hydroxycarbonate 0.10% and hydrogen peroxide 0.05-0.29%.
EFFECT: higher safety and effectiveness by blood oxygen saturation, stable osmotic activity, higher alkalinity and buffer capacity.
| Title | Year | Author | Number | 
|---|---|---|---|
| LYMPHO-SUBSITUTE FOR LOCAL MAINTAINING VIABILITY OF ORGANS AND TISSUES IN HYPOXIA AND ISCHEMIA | 2015 | 
 | RU2586292C1 | 
| DECOLORANT OF BLOOD | 2016 | 
 | RU2647371C1 | 
| BLEACHING AGENT | 2014 | 
 | RU2589682C1 | 
| AGENT FOR INCREASING RESISTANCE TO HYPOXIA | 2015 | 
 | RU2604129C2 | 
| BRUISE BLEACHER | 2014 | 
 | RU2539380C1 | 
| AGENT FOR INTRADERMAL BRUISE WHITENING | 2015 | 
 | RU2573382C1 | 
| MEANS FOR PHYSICAL ENDURANCE INCREASE | 2016 | 
 | RU2634271C1 | 
| ENERGY DRINK | 2016 | 
 | RU2639493C1 | 
| BLEACHING OPENER OF DRIED BLOOD FOR WRAPPING BANDAGES ADHERED TO A WOUND | 2016 | 
 | RU2653465C1 | 
| OXYGENATED WARM ALKALINE HYDROGEN PEROXIDE SOLUTION FOR INTRAPULMONARY INJECTION | 2023 | 
 | RU2831821C1 | 
Authors
Dates
2015-01-10—Published
2013-10-17—Filed